The price of shares in Israeli generic-drug giant Teva fell seven percent at the opening of Tuesday trading at the Tel Aviv Stock Exchange.
The drop followed a court ruling against Teva patents which took place after the market closed on Monday. Teva prices dropped about nine percent in New York, following the court decision.